OWLT - Owlet, Inc.
NYSE
->
Healthcare
->
Medical Devices
Lehi,
United States
Type: Equity
OWLT price evolution
OWLT
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $17.15 | $16.89 | $11.6 | $13.97 |
| Inventory | $10.6 | $8.1 | $7.74 | $6.49 |
| Total current assets | $52.28 | $42.53 | $40.02 | $39.94 |
| Long term investments | ||||
| Property, plant & equipment | $0.22 | $0.41 | $0.86 | $1.31 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $56.13 | $45.9 | $43.83 | $44.12 |
| Current liabilities | ||||
| Accounts payable | $11.52 | $17.51 | $16.06 | $13.68 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $35.69 | $42.15 | $39.45 | $45.09 |
| Long term debt | $4.58 | |||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $65.52 | $66.73 | $65.62 | $73.8 |
| Shareholders' equity | ||||
| Retained earnings | -$259.14 | -$253.53 | -$252.38 | -$255.66 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.29 | |||
| Short term investments | ||||
| Net receivables | $13.97 | $16 | $10.5 | $10.53 |
| Inventory | $6.49 | $18.5 | $18 | $7.91 |
| Total current assets | $39.94 | $51.3 | $135.8 | $1.56 |
| Long term investments | ||||
| Property, plant & equipment | $1.31 | $3.4 | $1.9 | $1.72 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $44.12 | $58.1 | $140 | $231.61 |
| Current liabilities | ||||
| Accounts payable | $13.68 | $30.4 | $27.8 | $16.38 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $45.09 | $66.6 | $69.1 | $0.32 |
| Long term debt | $8 | $10.18 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $73.8 | $68.7 | $84.8 | $31.9 |
| Shareholders' equity | ||||
| Retained earnings | -$255.66 | -$222.76 | -$143.42 | -$8.25 |
| Other shareholder equity | -$10.6 | $55.2 | ||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $22.12 | $35.45 | $14.75 | $21 |
| Cost of revenue | ||||
| Gross Profit | $11.55 | $16.8 | $6.55 | $9.87 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $16.37 | $24.79 | $12.29 | $12.95 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.02 | $0.01 | ||
| Interest expense | -$0.11 | -$0.14 | -$0.16 | -$0.19 |
| Net income | ||||
| Net income | -$6.76 | -$0.78 | $1.95 | -$8.22 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $54.01 | $69.2 | $75.8 | |
| Cost of revenue | ||||
| Gross Profit | $22.59 | $23.31 | $35 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $51.22 | $107.93 | $90.8 | $0.48 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.01 | $0.03 | ||
| Interest expense | -$3.19 | -$1.1 | -$27.9 | -$7.19 |
| Net income | ||||
| Net income | -$37.49 | -$79.34 | -$71.7 | -$8.25 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$0.72 | -$0.12 | -$0.05 | -$0.06 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $20.58 | $5.6 | $5.23 | $28.91 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $5.33 | -$1.19 | $1.84 | $5.33 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$0.06 | -$1.57 | -$2 | -$230 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $28.91 | -$0.88 | $120.6 | $231.74 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $5.33 | -$83.83 | $78 | $1.29 |
News
Fundamentals
| Market cap | $216.28M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 15.39M |
| Revenue | $93.33M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$13.81M |
| Revenue Q/Q | 27.44% |
| Revenue Y/Y | N/A |
| P/E ratio | -15.66 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.32 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.90 |
|---|---|
| ROA | -29.07% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.46 |
| Quick ratio | 1.17 |